Dr Leearne Hinch
Market Cap (AUD): 59.35M
Sector: Health Care
Last Trade (AUD): 0.66 +0 (+0%)
Tab Bar

1. About

INOVIQ Ltd (ASX:IIQ), formerly BARD1 Life Sciences Limited (ASX:BD1), is an Australian-based biotechnology company developing diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases.

The Company has commercialised the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. 

INOVIQ's cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk